Clinical Trial Update: Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study evaluating Pucotenlimab in combination with standard chemotherapy for pediatric rhabdomyosarcoma. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Drugs mentioned

• Pucotenlimab

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rhabdomyosarcoma, Pediatric Cancer | Phase 1, Phase 2 | Status: RECRUITING